Patient enrollment still looms large as the biggest risk to clinical trials, affecting trial timelines, budgets, and even trial viability. The Clinical Trials Database reports that 55 percent of trials were terminated due to low accrual rates. In fact, over 80 percent of clinical trials do not reach their recruitment goals, leading to delayed or failed execution of those studies.1
At Biorasi, our recruitment results speak for themselves. Compared to other CROS, our trials recruit eight times faster. Biorasi has built our reputation as a fast and flexible CRO for all recruitment needs – from study start to trial rescue – customizing our solutions to fit sponsor and patient goals.
Upon closer inspection, there is much more to the strategy of faster trials than simply adding a boost of speed. Biorasi’s recruiting results have been 20 years in the making, and we are constantly striving to find innovative and efficient methods for enrollment – inclusive of social media solutions.